Buyer Name: University Hospitals of Derby and Burton NHS Foundation Trust
Buyer Address: Royal Derby Hospital, Uttoxeter Road, Derby, UKF11, DE22 3NE, United Kingdom
Contact Name: Andrew Wilson
Contact Email: andrewwilson6@nhs.net
Framework for the Provision of Dose Banded Products & Patient Specific Chemotherapy Services
University Hospitals of Derby and Burton NHS Foundation Trust
Buyer Contact Info
Status
complete
complete
Procedure
direct
direct
Value
9000000.0 GBP
9000000.0 GBP
Published
26 Jan 2026, 10:31
26 Jan 2026, 10:31
Deadline
n/a
n/a
Contract Start
30 Jun 2026, 23:00
30 Jun 2026, 23:00
Contract End
30 Jun 2027, 22:59
30 Jun 2027, 22:59
Category
n/a
n/a
CPV
33600000 - Pharmaceutical products
33600000 - Pharmaceutical products
Region
n/a
n/a
Awarded To
Baxter Healthcare Limited, ITH Pharma Ltd, BATH ASU
Baxter Healthcare Limited, ITH Pharma Ltd, BATH ASU
Official Source
Open Find a Tender
Open Find a Tender
Description
Framework for the Provision of Dose Banded Products & Patient Specific Chemotherapy Services to member Trusts of the East Midlands Pharmacy Collaborative.
Linked Documents
No linked documents found for this notice.
Opportunity Context
Lots
Lot 1 Status: complete
Lot 1 SME Suitable: Yes
Documents
Document Description: Not published
Awards
Award Title: Contract Extension
Raw Notice JSON
Expand raw payload
{
"awards": [
{
"aboveThreshold": true,
"contractPeriod": {
"endDate": "2027-06-30T23:59:59+01:00",
"maxExtentDate": "2028-06-30T23:59:59+01:00",
"startDate": "2026-07-01T00:00:00+01:00"
},
"documents": [
{
"datePublished": "2026-01-26T10:31:09Z",
"description": "Transparency notice on Find a Tender",
"documentType": "awardNotice",
"format": "text/html",
"id": "006485-2026",
"noticeType": "UK5",
"url": "https://www.find-tender.service.gov.uk/Notice/006485-2026"
}
],
"hasRenewal": true,
"id": "1",
"items": [
{
"additionalClassifications": [
{
"description": "Pharmaceutical products",
"id": "33600000",
"scheme": "CPV"
}
],
"id": "1",
"relatedLot": "1"
}
],
"mainProcurementCategory": "goods",
"milestones": [
{
"dueDate": "2026-04-01T23:59:59+01:00",
"id": "1",
"status": "scheduled",
"type": "futureSignatureDate"
}
],
"relatedLots": [
"1"
],
"renewal": {
"description": "Dependent on outcome of OBC and if a FBC is required for Spend Controls"
},
"status": "pending",
"suppliers": [
{
"id": "GB-COH-00461365",
"name": "Baxter Healthcare Limited"
},
{
"id": "GB-COH-06569105",
"name": "ITH Pharma Ltd"
},
{
"id": "GB-COH-05548345",
"name": "BATH ASU"
}
],
"title": "Contract Extension",
"value": {
"amount": 9000000.0,
"amountGross": 9000000.0,
"currency": "GBP"
}
}
],
"buyer": {
"id": "GB-PPON-PQZD-7532-NDHL",
"name": "University Hospitals of Derby and Burton NHS Foundation Trust"
},
"date": "2026-01-26T10:31:09Z",
"id": "006485-2026",
"initiationType": "tender",
"language": "en",
"ocid": "ocds-h6vhtk-060e0f",
"parties": [
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Derby",
"postalCode": "DE22 3NE",
"region": "UKF11",
"streetAddress": "Royal Derby Hospital, Uttoxeter Road\u00a0"
},
"contactPoint": {
"email": "andrewwilson6@nhs.net",
"name": "Andrew Wilson"
},
"details": {
"classifications": [
{
"description": "Public authority - central government",
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE"
}
],
"url": "https://www.uhdb.nhs.uk"
},
"id": "GB-PPON-PQZD-7532-NDHL",
"identifier": {
"id": "PQZD-7532-NDHL",
"scheme": "GB-PPON"
},
"name": "University Hospitals of Derby and Burton NHS Foundation Trust",
"roles": [
"buyer"
]
},
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Newbury",
"postalCode": "RG20 7QW",
"region": "UKJ11",
"streetAddress": "Wallingford Rd"
},
"contactPoint": {
"email": "contractsuk@baxter.com"
},
"details": {
"scale": "large",
"vcse": false
},
"id": "GB-COH-00461365",
"identifier": {
"id": "00461365",
"scheme": "GB-COH"
},
"name": "Baxter Healthcare Limited",
"roles": [
"supplier"
]
},
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "London",
"postalCode": "NW10 7NZ",
"region": "UKI72",
"streetAddress": "Unit 4 Premiere Park"
},
"contactPoint": {
"email": "anthony@ithgroup.uk"
},
"details": {
"scale": "sme",
"vcse": false
},
"id": "GB-COH-06569105",
"identifier": {
"id": "06569105",
"scheme": "GB-COH"
},
"name": "ITH Pharma Ltd",
"roles": [
"supplier"
]
},
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Corsham",
"postalCode": "SN13 9RG",
"region": "UKK15",
"streetAddress": "Unit A15, Fiveways Light Ind Est, West Wells Road"
},
"contactPoint": {
"email": "alison.davis@pharmaxo.com"
},
"details": {
"scale": "large",
"vcse": false
},
"id": "GB-COH-05548345",
"identifier": {
"id": "05548345",
"scheme": "GB-COH"
},
"name": "BATH ASU",
"roles": [
"supplier"
]
}
],
"tag": [
"award",
"contract"
],
"tender": {
"description": "Framework for the Provision of Dose Banded Products \u0026 Patient Specific Chemotherapy Services to member Trusts of the East Midlands Pharmacy Collaborative.",
"documents": [
{
"description": "Not published",
"documentType": "conflictOfInterest",
"id": "conflictOfInterest"
}
],
"id": "D100/C358943",
"legalBasis": {
"id": "2023/54",
"scheme": "UKPGA",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
},
"lots": [
{
"id": "1",
"status": "complete",
"suitability": {
"sme": true
}
}
],
"participationFees": [
{
"description": "N.A",
"id": "ocds-h6vhtk-060e0f",
"type": [
"win"
]
}
],
"procurementMethod": "direct",
"procurementMethodDetails": "Direct award",
"procurementMethodRationale": "The estimated revised spend for EMPC for this new Contract value now exceeds the Cabinet Office Spend Control Threshold of \u00a320 million for a two-year framework period. This is due to the increase requirements for additional molecules across our member Trusts. \nUnder Cabinet Office Spend Control requirements, EMPC are required to submit a business case for approval prior to publishing the new tender.\nThe current contract is due to expire on 30 June 2026. To maintain continuity of patient care and ensure uninterrupted product and service delivery, EMPC will extend the existing agreements with current Awarded Suppliers beyond this date. New Procurement timescales will be communicated to the market as soon as possible. \nIt is anticipated the new Tender will be published in the summer of 2026 if spend control approval is given. \nA UK 06 Contract Award and a UK 07 Contract Details Notice will be published on the Find a Tender portal.",
"procurementMethodRationaleClassifications": [
{
"id": "switchingDirectAward"
}
],
"riskDetails": "No risk to extending as Suppliers are known to the Trusts. \nThe risk is having no continuity of essential contract performance management and may mean that Trusts may have to find alternative sources of supply outside of Contract.",
"status": "complete",
"techniques": {
"frameworkAgreement": {
"periodRationale": "The estimated revised spend for EMPC for this new Contract value now exceeds the Cabinet Office Spend Control Threshold of \u00a320 million for a two-year framework period. This is due to the increase requirements for additional molecules across our member Trusts. \nUnder Cabinet Office Spend Control requirements, EMPC are required to submit a business case for approval prior to publishing the new tender.\nThe current contract is due to expire on 30 June 2026. To maintain continuity of patient care and ensure uninterrupted product and service delivery, EMPC will extend the existing agreements with current Awarded Suppliers beyond this date. New Procurement timescales will be communicated to the market as soon as possible. \nIt is anticipated the new Tender will be published in the summer of 2026 if spend control approval is given. \nA UK 06 Contract Award and a UK 07 Contract Details Notice will be published on the Find a Tender portal.",
"type": "closed"
},
"hasFrameworkAgreement": true
},
"title": "Framework for the Provision of Dose Banded Products \u0026 Patient Specific Chemotherapy Services"
}
}